Press "Enter" to skip to content

California May Join Other States in Drug Price Transparency Legislation

From Kaiser Health News: Potential new legislation (SB 17) being introduced in California would require drug companies to give California 60 days’ notice to state agencies and health insurers anytime they plan to raise the price of a drug by 16 percent or more over two years. They would also have to explain why the increases are necessary. In addition, health insurers would have to report what percentage of premium increases are caused by drug spending.  Other states, including Maryland, Vermont, Nevada and New York, have passed similar laws aimed at bringing more transparency to prices and curbing price gouging.

Read more: